Coelho Rogerio Vivaldi, Director at Crinetics Pharmaceuticals, Inc. (CRNX), sold 5,000 shares at $36.08 ($181K) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Open-market sale of $181k CRNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.08 | 4,477 | $162K | 89.4% |
| 2 | $36.77 | 523 | $19K | 10.6% |
| Total | $36.15 avg | 5,000 | $181K | 100% |
| Filing → |
| ONCE | SELL | 2016-07-19 | $371K | — | Filing → |
| ONCE | SELL | 2016-04-22 | $280K | — | Filing → |
| ONCE | SELL | 2015-10-14 | $1.2M | — | Filing → |